Fermentalg SA (EPA:ALGAE)
0.5580
-0.0160 (-2.79%)
Apr 24, 2026, 3:19 PM CET
Fermentalg Revenue
In the year 2025, Fermentalg had annual revenue of 13.38M EUR with 16.41% growth. Fermentalg had revenue of 5.78M in the half year ending December 31, 2025, with 236.58% growth.
Revenue
13.38M
Revenue Growth
+16.41%
P/S Ratio
3.85
Revenue / Employee
212.44K
Employees
63
Market Cap
51.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.38M | 1.89M | 16.41% |
| Dec 31, 2024 | 11.50M | 7.44M | 183.39% |
| Dec 31, 2023 | 4.06M | -3.59M | -46.95% |
| Dec 31, 2022 | 7.65M | 2.00M | 35.43% |
| Dec 31, 2021 | 5.65M | 3.44M | 156.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 20.96M |
| Adocia | 12.88M |
| Innate Pharma | 9.01M |
| Advicenne | 5.90M |
| MaaT Pharma | 4.52M |
| ABIONYX Pharma | 4.10M |
| Nicox | 3.32M |
| Valerio Therapeutics Société anonyme | 1.83M |